
Results
53
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
53 companies
IREN
Market Cap: US$12.6b
Operates in the vertically integrated data center business in Australia and Canada.
IREN
US$37.77
7D
-10.0%
1Y
284.6%
Tempus AI
Market Cap: US$10.5b
Operates as a healthcare technology company.
TEM
US$59.05
7D
-8.1%
1Y
72.4%
Vipshop Holdings
Market Cap: US$8.9b
Operates online platforms in the People's Republic of China.
VIPS
US$17.69
7D
-9.7%
1Y
31.3%
Rigetti Computing
Market Cap: US$7.4b
Through its subsidiaries, builds quantum computers and the superconducting quantum processors the United States, the United Kingdom, rest of Europe, Asia, and internationally.
RGTI
US$22.15
7D
-9.6%
1Y
45.2%
Sunrun
Market Cap: US$4.4b
Designs, develops, installs, sells, owns, and maintains residential solar energy systems in the United States.
RUN
US$18.40
7D
-8.7%
1Y
98.9%
Sezzle
Market Cap: US$2.2b
Operates as a technology-enabled payments company primarily in the United States and Canada.
SEZL
US$63.48
7D
-13.8%
1Y
48.9%
National Vision Holdings
Market Cap: US$2.1b
Through its subsidiaries, operates as an optical retailer in the United States.
EYE
US$25.82
7D
-8.8%
1Y
147.8%
Pagaya Technologies
Market Cap: US$1.7b
A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services and other service providers, their customers, and asset investors in the United States, Israel, and the Cayman Islands.
PGY
US$20.90
7D
-8.1%
1Y
125.0%
Willdan Group
Market Cap: US$1.6b
Provides professional, technical, and consulting services primarily in the United States.
WLDN
US$103.66
7D
-8.2%
1Y
172.1%
Kodiak Sciences
Market Cap: US$1.5b
A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.
KOD
US$27.96
7D
-10.0%
1Y
181.0%
Array Technologies
Market Cap: US$1.4b
Manufactures and sells solar tracking technology products in the United States, Spain, Brazil, Australia, and internationally.
ARRY
US$9.22
7D
-9.5%
1Y
36.8%
Power Solutions International
Market Cap: US$1.4b
Designs, engineers, manufactures, markets, and sells engines and power systems in the United States, North America, the Pacific Rim, Europe, and internationally.
PSIX
US$57.14
7D
-14.1%
1Y
92.1%
Herbalife
Market Cap: US$1.3b
Provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific.
HLF
US$12.89
7D
-9.1%
1Y
92.7%
Monte Rosa Therapeutics
Market Cap: US$1.0b
A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.
GLUE
US$15.68
7D
-11.1%
1Y
125.9%
United States Antimony
Market Cap: US$724.7m
Produces and sells antimony, zeolite, and precious metals in the United States and Canada.
UAMY
US$5.02
7D
-20.9%
1Y
183.6%
Gossamer Bio
Market Cap: US$722.1m
A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.
GOSS
US$3.10
7D
-9.9%
1Y
242.7%
BlackSky Technology
Market Cap: US$689.3m
Operates as a space-based intelligence company in North America, the Middle East, the Asia Pacific, and internationally.
BKSY
US$18.75
7D
-11.6%
1Y
73.8%
Lyell Immunopharma
Market Cap: US$670.3m
A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.
LYEL
US$30.78
7D
-20.3%
1Y
140.5%
ProKidney
Market Cap: US$661.8m
A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.
PROK
US$2.24
7D
-12.8%
1Y
32.5%
Organogenesis Holdings
Market Cap: US$657.4m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$5.18
7D
-11.8%
1Y
61.9%
Invivyd
Market Cap: US$566.5m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
IVVD
US$2.47
7D
-12.1%
1Y
457.4%
Alto Neuroscience
Market Cap: US$557.3m
Operates as a clinical-stage biopharmaceutical company in the United States.
ANRO
US$17.80
7D
-10.5%
1Y
320.8%
NovaBridge Biosciences
Market Cap: US$456.6m
A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.
NBP
US$3.98
7D
-14.0%
1Y
368.2%
Contango Ore
Market Cap: US$405.9m
An exploration stage company, engages in the exploration and development of mineral properties in Alaska, the United States.
CTGO
US$26.41
7D
-9.8%
1Y
163.6%
U.S. Gold
Market Cap: US$282.3m
Engages in the exploration, evaluation, and development of mineral properties in the United States.
USAU
US$19.41
7D
-13.6%
1Y
216.6%
American Resources
Market Cap: US$270.7m
Engages in the production of rare earth and critical mineral concentrates for the infrastructure and electrification markets.
AREC
US$2.48
7D
-8.8%
1Y
145.5%
KORU Medical Systems
Market Cap: US$263.6m
Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.
KRMD
US$5.81
7D
-10.3%
1Y
50.9%
So-Young International
Market Cap: US$251.1m
Operates an online platform for consumption healthcare services in the People’s Republic of China.
SY
US$2.56
7D
-8.6%
1Y
208.4%
Niu Technologies
Market Cap: US$246.4m
Designs, manufactures, and sells electric scooters in the People's Republic of China, Europe, and internationally.
NIU
US$3.03
7D
-8.2%
1Y
69.3%
Climb Bio
Market Cap: US$192.4m
A clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases.
CLYM
US$4.00
7D
-17.5%
1Y
122.2%
Quince Therapeutics
Market Cap: US$181.5m
A biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.
QNCX
US$3.35
7D
-8.5%
1Y
79.1%
DeFi Development
Market Cap: US$158.9m
Operates an AI-powered online platform that connects the commercial real estate industry by providing data and software subscriptions to multifamily and commercial property professionals.
DFDV
US$5.05
7D
-8.5%
1Y
628.1%
Microbot Medical
Market Cap: US$137.7m
A medical device company that focuses on transforming endovascular procedures through advanced robotic technology.
MBOT
US$2.00
7D
-8.3%
1Y
78.6%
blueharbor bank
Market Cap: US$92.3m
Provides various banking products and services in North Carolina.
BLHK
US$31.20
7D
-8.2%
1Y
41.9%
9F
Market Cap: US$88.5m
Provides digital technology and wealth management services in the People’s Republic of China and Hong Kong.
JFU
US$6.39
7D
-11.5%
1Y
323.2%
AEye
Market Cap: US$85.6m
Provides lidar systems for vehicle autonomy, advanced driver-assistance systems, and robotic vision applications in the United States, Europe, and the Asia Pacific.
LIDR
US$1.84
7D
-18.6%
1Y
44.9%